Hepatic dysfunction is primarily caused by nonalcoholic fatty liver disease (NAFLD).
Recently, berberine (BBR) has attracted researchers' interest with its hepatic protective …

The incidence of Non-Alcoholic Fatty Liver Disease (NAFLD) has been rapidly increasing
during the last decade. It is a relevant health problem that affects 25% of the general …

As lifestyle and diet structure impact our health, non-alcoholic fatty liver disease (NAFLD) is
prevalent all over the world. Some phytomedicines containing berberine (BBR) have been …

Berberine (BBR), an active ingredient from nature plants, has demonstrated multiple
biological activities and pharmacological effects in a series of metabolic diseases including …

Non-alcoholic fatty liver disease (NAFLD) is a global metabolic disease with high
prevalence in both adults and children. Importantly, NAFLD is becoming the main cause of …

Objectives A randomized, parallel controlled, open-label clinical trial was conducted to
evaluate the effect of a botanic compound berberine (BBR) on NAFLD. Methods A …

Nonalcoholic fatty liver disease (NAFLD) is a globally observed metabolic disease with high
prevalence both in adults and children. However, there is no efficient medication available …

Non-alcoholic fatty liver disease (NAFLD) is the predominant cause of chronic liver
conditions, and its progression is marked by evolution to non-alcoholic steatosis …

Background Non-alcoholic fatty liver disease (NAFLD) is becoming increasingly prevalent
worldwide, emerging as a significant health issue on a global scale. Berberine exhibits …

Aim. To assess the efficacy of berberine in the treatment of nonalcoholic fatty liver disease
through meta‐analysis. Method. We searched Embase, Pubmed, Cochrane Library, and so …